Top Markets
Coin of the day
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
Classement en actions #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Prix de l'action
$0.00060315
Dernière synchronisation: 2024-09-27
Capitalisation boursière
$1.65M
Changement (1 jour)
19.64%
Changement (1 an)
0.00%
Pays
SE
Échange Amniotics AB (publ) (AMNI)

Catégorie

EPS pour Amniotics AB (publ) (AMNI)
EPS au December 2023 TTM : $-0.04
Selon les derniers rapports financiers et le cours de l'action de Amniotics AB (publ), l’EPS actuel de la société (TTM) est de $-0.04. À la fin de 2022, la société avait un EPS de $-0.03 une diminution par rapport à celui de 2021, qui était de $-0.04.
Historique de l'EPS de Amniotics AB (publ) de 2018 à 2026
EPS à la fin de chaque année
Année EPS Changez
2026 (TTM) $-0.04 -96.18%
2023 0.00 -96.18%
2022 $-0.03 -21.10%
2021 $-0.04 77.18%
2020 $-0.02 237.70%
2019 $-0.01 45.24%
2018 0.00 0.00%
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
$17.32 -47,293.46%
US
$27.74 -75,685.83%
NL
- -
CH
- -
KR
$13.70 -37,429.97%
BE